Figur8, a Boston, MA-based leader in the measure of musculoskeletal (MSK) health, has successfully closed a $25m Series A-1 funding.
The round was led by First Spark Ventures (FSV) with participation from DigiTx Partners and Phoenix Venture Partners.
The company intends to use the funds to drive growth and adoption of its core bioMotion Assessment Platform (bMAP).
Led by Nan-Wei Gong, founder and CEO, Figur8 is a market leader for standardizing musculoskeletal (MSK) health and injury recovery data. Through its bioMotion Assessment Platform (bMAP), the company empowers individuals to monitor and optimize their injury recovery, physical performance and overall health, while also enabling providers, patients and payers to access valuable data for advanced insights, and more personalized care and recovery.
The bMAP produces objective data for musculoskeletal care and injury recovery. Advanced data empowers providers to better communicate symptoms, diagnosis and progress, while enabling payers to improve claims and underwriting processes, optimize risk management strategies, and promote faster recovery among injured workers.
FinSMEs
08/08/2023